Is JetBlue The Best Airline Stock?
Following a general trend of improvement among airline stocks, shares…
Sell
50
ERFSF Quote, Financials, Valuation and Earnings
Last price:
$69.10
Seasonality move
:
4.2%
Day range:
$66.13 - $70.14
52-week range:
$46.37 - $83.02
Dividend yield:
1.76%
P/E ratio:
28.01x
P/S ratio:
1.70x
P/B ratio:
57.94x
Volume:
577
Avg. volume:
1.8K
1-year change:
39.96%
Market cap:
$12.3B
Revenue:
$7.5B
EPS (TTM):
$2.55
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ERFSF
Eurofins Scientific SE
|
-- | -- | -- | -- | -- |
|
ALVO
Alvotech
|
$117.2M | -$0.03 | 9.08% | -87.15% | $22.17 |
|
AUNA
Auna SA
|
$339.3M | $0.18 | 11.49% | 114.95% | $10.42 |
|
CVM
CEL-SCI Corp.
|
-- | -- | -- | -- | $42.50 |
|
MLEC
Moolec Science SA
|
$2M | -- | 421.59% | -- | -- |
|
PROCF
Sofgen Pharma SA
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ERFSF
Eurofins Scientific SE
|
$69.10 | -- | $12.3B | 28.01x | $0.68 | 1.76% | 1.70x |
|
ALVO
Alvotech
|
$5.75 | $22.17 | $1.8B | 24.97x | $0.00 | 0% | 3.17x |
|
AUNA
Auna SA
|
$4.71 | $10.42 | $348.6M | 6.81x | $0.00 | 0% | 0.30x |
|
CVM
CEL-SCI Corp.
|
$6.48 | $42.50 | $19.7M | -- | $0.00 | 0% | -- |
|
MLEC
Moolec Science SA
|
$0.44 | -- | $1.7M | -- | $0.00 | 0% | 1.65x |
|
PROCF
Sofgen Pharma SA
|
$0.03 | -- | $57.8M | -- | $0.00 | 0% | 0.01x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ERFSF
Eurofins Scientific SE
|
43.41% | -0.376 | -- | 1.08x |
|
ALVO
Alvotech
|
115.99% | 2.339 | 50.24% | 0.54x |
|
AUNA
Auna SA
|
68.8% | 1.304 | 194.28% | 0.70x |
|
CVM
CEL-SCI Corp.
|
58.65% | 1.679 | 143.38% | 0.32x |
|
MLEC
Moolec Science SA
|
67.66% | -0.564 | 33.83% | 0.84x |
|
PROCF
Sofgen Pharma SA
|
-- | 573.065 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ERFSF
Eurofins Scientific SE
|
-- | -- | 5.27% | 8.55% | -- | -- |
|
ALVO
Alvotech
|
$78.7M | $1.2M | 7.33% | -- | 1.05% | -$84M |
|
AUNA
Auna SA
|
$118.6M | $43.8M | 3.64% | 11.53% | 13.85% | $25.8M |
|
CVM
CEL-SCI Corp.
|
-$959K | -$5.5M | -123.39% | -266.61% | -- | -$3.9M |
|
MLEC
Moolec Science SA
|
-$71.6K | -$2.9M | -45.87% | -93.42% | -173.87% | -$1.1M |
|
PROCF
Sofgen Pharma SA
|
-- | -- | -- | -- | -- | -- |
Eurofins Scientific SE vs. Competitors
-
Which has Higher Returns ERFSF or ALVO?
Alvotech has a net margin of -- compared to Eurofins Scientific SE's net margin of -4.62%. Eurofins Scientific SE's return on equity of 8.55% beat Alvotech's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ERFSFEurofins Scientific SE-- -- $9.6B ALVOAlvotech69.22% -$0.02 $1.1B -
What do Analysts Say About ERFSF or ALVO?
Eurofins Scientific SE has a consensus price target of --, signalling downside risk potential of --. On the other hand Alvotech has an analysts' consensus of $22.17 which suggests that it could grow by 285.51%. Given that Alvotech has higher upside potential than Eurofins Scientific SE, analysts believe Alvotech is more attractive than Eurofins Scientific SE.
Company Buy Ratings Hold Ratings Sell Ratings ERFSFEurofins Scientific SE0 0 0 ALVOAlvotech3 1 0 -
Is ERFSF or ALVO More Risky?
Eurofins Scientific SE has a beta of 0.637, which suggesting that the stock is 36.263% less volatile than S&P 500. In comparison Alvotech has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock ERFSF or ALVO?
Eurofins Scientific SE has a quarterly dividend of $0.68 per share corresponding to a yield of 1.76%. Alvotech offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Eurofins Scientific SE pays 28.14% of its earnings as a dividend. Alvotech pays out -- of its earnings as a dividend. Eurofins Scientific SE's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ERFSF or ALVO?
Eurofins Scientific SE quarterly revenues are --, which are smaller than Alvotech quarterly revenues of $113.7M. Eurofins Scientific SE's net income of -- is lower than Alvotech's net income of -$5.3M. Notably, Eurofins Scientific SE's price-to-earnings ratio is 28.01x while Alvotech's PE ratio is 24.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Eurofins Scientific SE is 1.70x versus 3.17x for Alvotech. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ERFSFEurofins Scientific SE1.70x 28.01x -- -- ALVOAlvotech3.17x 24.97x $113.7M -$5.3M
-
Which has Higher Returns ERFSF or AUNA?
Auna SA has a net margin of -- compared to Eurofins Scientific SE's net margin of 4.74%. Eurofins Scientific SE's return on equity of 8.55% beat Auna SA's return on equity of 11.53%.
Company Gross Margin Earnings Per Share Invested Capital ERFSFEurofins Scientific SE-- -- $9.6B AUNAAuna SA37.52% $0.18 $1.6B -
What do Analysts Say About ERFSF or AUNA?
Eurofins Scientific SE has a consensus price target of --, signalling downside risk potential of --. On the other hand Auna SA has an analysts' consensus of $10.42 which suggests that it could grow by 121.16%. Given that Auna SA has higher upside potential than Eurofins Scientific SE, analysts believe Auna SA is more attractive than Eurofins Scientific SE.
Company Buy Ratings Hold Ratings Sell Ratings ERFSFEurofins Scientific SE0 0 0 AUNAAuna SA2 2 0 -
Is ERFSF or AUNA More Risky?
Eurofins Scientific SE has a beta of 0.637, which suggesting that the stock is 36.263% less volatile than S&P 500. In comparison Auna SA has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock ERFSF or AUNA?
Eurofins Scientific SE has a quarterly dividend of $0.68 per share corresponding to a yield of 1.76%. Auna SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Eurofins Scientific SE pays 28.14% of its earnings as a dividend. Auna SA pays out -- of its earnings as a dividend. Eurofins Scientific SE's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ERFSF or AUNA?
Eurofins Scientific SE quarterly revenues are --, which are smaller than Auna SA quarterly revenues of $316.1M. Eurofins Scientific SE's net income of -- is lower than Auna SA's net income of $15M. Notably, Eurofins Scientific SE's price-to-earnings ratio is 28.01x while Auna SA's PE ratio is 6.81x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Eurofins Scientific SE is 1.70x versus 0.30x for Auna SA. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ERFSFEurofins Scientific SE1.70x 28.01x -- -- AUNAAuna SA0.30x 6.81x $316.1M $15M
-
Which has Higher Returns ERFSF or CVM?
CEL-SCI Corp. has a net margin of -- compared to Eurofins Scientific SE's net margin of --. Eurofins Scientific SE's return on equity of 8.55% beat CEL-SCI Corp.'s return on equity of -266.61%.
Company Gross Margin Earnings Per Share Invested Capital ERFSFEurofins Scientific SE-- -- $9.6B CVMCEL-SCI Corp.-- -$1.36 $17M -
What do Analysts Say About ERFSF or CVM?
Eurofins Scientific SE has a consensus price target of --, signalling downside risk potential of --. On the other hand CEL-SCI Corp. has an analysts' consensus of $42.50 which suggests that it could grow by 555.86%. Given that CEL-SCI Corp. has higher upside potential than Eurofins Scientific SE, analysts believe CEL-SCI Corp. is more attractive than Eurofins Scientific SE.
Company Buy Ratings Hold Ratings Sell Ratings ERFSFEurofins Scientific SE0 0 0 CVMCEL-SCI Corp.1 0 0 -
Is ERFSF or CVM More Risky?
Eurofins Scientific SE has a beta of 0.637, which suggesting that the stock is 36.263% less volatile than S&P 500. In comparison CEL-SCI Corp. has a beta of 0.487, suggesting its less volatile than the S&P 500 by 51.259%.
-
Which is a Better Dividend Stock ERFSF or CVM?
Eurofins Scientific SE has a quarterly dividend of $0.68 per share corresponding to a yield of 1.76%. CEL-SCI Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Eurofins Scientific SE pays 28.14% of its earnings as a dividend. CEL-SCI Corp. pays out -- of its earnings as a dividend. Eurofins Scientific SE's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ERFSF or CVM?
Eurofins Scientific SE quarterly revenues are --, which are smaller than CEL-SCI Corp. quarterly revenues of --. Eurofins Scientific SE's net income of -- is lower than CEL-SCI Corp.'s net income of -$5.7M. Notably, Eurofins Scientific SE's price-to-earnings ratio is 28.01x while CEL-SCI Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Eurofins Scientific SE is 1.70x versus -- for CEL-SCI Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ERFSFEurofins Scientific SE1.70x 28.01x -- -- CVMCEL-SCI Corp.-- -- -- -$5.7M
-
Which has Higher Returns ERFSF or MLEC?
Moolec Science SA has a net margin of -- compared to Eurofins Scientific SE's net margin of -166.47%. Eurofins Scientific SE's return on equity of 8.55% beat Moolec Science SA's return on equity of -93.42%.
Company Gross Margin Earnings Per Share Invested Capital ERFSFEurofins Scientific SE-- -- $9.6B MLECMoolec Science SA-4.7% -$0.07 $21.1M -
What do Analysts Say About ERFSF or MLEC?
Eurofins Scientific SE has a consensus price target of --, signalling downside risk potential of --. On the other hand Moolec Science SA has an analysts' consensus of -- which suggests that it could grow by 6796.55%. Given that Moolec Science SA has higher upside potential than Eurofins Scientific SE, analysts believe Moolec Science SA is more attractive than Eurofins Scientific SE.
Company Buy Ratings Hold Ratings Sell Ratings ERFSFEurofins Scientific SE0 0 0 MLECMoolec Science SA0 0 0 -
Is ERFSF or MLEC More Risky?
Eurofins Scientific SE has a beta of 0.637, which suggesting that the stock is 36.263% less volatile than S&P 500. In comparison Moolec Science SA has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock ERFSF or MLEC?
Eurofins Scientific SE has a quarterly dividend of $0.68 per share corresponding to a yield of 1.76%. Moolec Science SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Eurofins Scientific SE pays 28.14% of its earnings as a dividend. Moolec Science SA pays out -- of its earnings as a dividend. Eurofins Scientific SE's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ERFSF or MLEC?
Eurofins Scientific SE quarterly revenues are --, which are smaller than Moolec Science SA quarterly revenues of $1.5M. Eurofins Scientific SE's net income of -- is lower than Moolec Science SA's net income of -$2.5M. Notably, Eurofins Scientific SE's price-to-earnings ratio is 28.01x while Moolec Science SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Eurofins Scientific SE is 1.70x versus 1.65x for Moolec Science SA. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ERFSFEurofins Scientific SE1.70x 28.01x -- -- MLECMoolec Science SA1.65x -- $1.5M -$2.5M
-
Which has Higher Returns ERFSF or PROCF?
Sofgen Pharma SA has a net margin of -- compared to Eurofins Scientific SE's net margin of --. Eurofins Scientific SE's return on equity of 8.55% beat Sofgen Pharma SA's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ERFSFEurofins Scientific SE-- -- $9.6B PROCFSofgen Pharma SA-- -- -- -
What do Analysts Say About ERFSF or PROCF?
Eurofins Scientific SE has a consensus price target of --, signalling downside risk potential of --. On the other hand Sofgen Pharma SA has an analysts' consensus of -- which suggests that it could grow by 19820.32%. Given that Sofgen Pharma SA has higher upside potential than Eurofins Scientific SE, analysts believe Sofgen Pharma SA is more attractive than Eurofins Scientific SE.
Company Buy Ratings Hold Ratings Sell Ratings ERFSFEurofins Scientific SE0 0 0 PROCFSofgen Pharma SA0 0 0 -
Is ERFSF or PROCF More Risky?
Eurofins Scientific SE has a beta of 0.637, which suggesting that the stock is 36.263% less volatile than S&P 500. In comparison Sofgen Pharma SA has a beta of 61.716, suggesting its more volatile than the S&P 500 by 6071.584%.
-
Which is a Better Dividend Stock ERFSF or PROCF?
Eurofins Scientific SE has a quarterly dividend of $0.68 per share corresponding to a yield of 1.76%. Sofgen Pharma SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Eurofins Scientific SE pays 28.14% of its earnings as a dividend. Sofgen Pharma SA pays out -- of its earnings as a dividend. Eurofins Scientific SE's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ERFSF or PROCF?
Eurofins Scientific SE quarterly revenues are --, which are smaller than Sofgen Pharma SA quarterly revenues of --. Eurofins Scientific SE's net income of -- is lower than Sofgen Pharma SA's net income of --. Notably, Eurofins Scientific SE's price-to-earnings ratio is 28.01x while Sofgen Pharma SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Eurofins Scientific SE is 1.70x versus 0.01x for Sofgen Pharma SA. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ERFSFEurofins Scientific SE1.70x 28.01x -- -- PROCFSofgen Pharma SA0.01x -- -- --
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Netflix Buy Warner Bros?
Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…
Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
61
PLAB alert for Dec 12
Photronics, Inc. [PLAB] is up 6.18% over the past day.
Buy
77
DHIL alert for Dec 12
Diamond Hill Investment Group, Inc. [DHIL] is up 44.46% over the past day.
Buy
100
WRBY alert for Dec 12
Warby Parker, Inc. [WRBY] is up 2.23% over the past day.
